“This is the most optimistic, cautiously optimistic, I’ve been so far as compared to other cases,” said Todd MacLaughlan, the CEO of Profounda, the manufacturer of the drug. He is more optimistic than in past cases because the patient received the drug very quickly — it was delivered to a Florida hospital in less than 30 minutes, according to CNN.
The drug is Impavido, or generically, miltefosine. One treatment can cost $48,000, and it just this year became available for hospitals to order.
The amoeba, Naegleria fowlerii, causes primary amebic meningoencephalitis, or PAM, which is nearly always fatal.
More articles on patient safety:
Hospitals disposing of organs, refusing transplants to maintain federal performance ratings
Ochsner hospital transfers 40 critically ill patients due to massive floods
Too much of a good thing? Not possible for hand hygiene compliance, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
